CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs
-
03/01/2021
-
-
Source: Emerg Infect Dis. 27(3):985-987
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.
-
Subjects:
-
Source:
-
Pubmed ID:33622487
-
Pubmed Central ID:PMC7920658
-
Document Type:
-
Place as Subject:
-
Volume:27
-
Issue:3
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
[PDF-630.67 KB]
Supporting Files
-
gif 
jpeg 
xml
